Wednesday, March 30, 2016

How to Contact Your Elected Officials

Please contact your Congressional Representatives and demand that corn be declared an allergen.  Thank you all for your support.


How to Contact Your Elected Officials:
https://www.usa.gov/elected-officials


Corn Allergy Advocacy/Resources
@CornAllergy911

Friday, March 25, 2016

"Allergy Advisor," Published Corn Allergy Study

“Maize allergy can occur to the ingestion of maize or maize derivatives, or to the inhalation of maize flour or maize pollen. A true allergy to maize has been said to be uncommon,1 but recent studies have shown that diagnostic methods used in the past may not have been accurate, so that maize allergy was underdiagnosed.”


“Allergic reactions, including dermatitis, have been described with maize by-products, corn syrup, corn dextrimaltose, corn invert sugar, corn isomerised dextrose and corn D-psicose.20,21,22 This demonstrates that one or more allergens remain in maize throughout processing and are still present in maize derivatives. Intravenous administration of a maize-derived dextrose solution has resulted in anaphylaxis.”


“Because maize is eaten in various ways . . . and the specific allergen profile of various maize derivatives is not known, it may be necessary to challenge each derivative separately. Each derivative may have a different potential for triggering adverse reactions. It is therefore useful to assess a person's tolerance of each component.”

Prof Janice M. Joneja Ph. D., RDN
“It has been my experience through many years of managing food allergies and intolerances that adverse reactions to corn and corn derivatives are frequently undiagnosed, and the incidence of corn allergy is greatly underestimated. Because skin tests and tests for anti-corn antibodies in blood are generally negative, the assumption that corn allergy is uncommon has been made to the detriment of many corn-sensitive individuals - usually children. As this case study demonstrates, corn allergy is an example of a food allergy that can only be successfully and accurately identified by elimination and challenge. Corn is not unique in this respect since allergy to a number of foods is often overlooked because the standard allergy tests are negative. We have to keep in mind that because of the high incidence of false negative, and sometimes false positive results, estimates of the efficacy of skin and blood tests for food allergy never exceed 50%, and many practitioners rate them even lower. Even when a positive skin or blood test indicates the presence of anti-food IgE, elimination and challenge must be undertaken to demonstrate that the food does in fact cause clinical symptoms when it is consumed. It is more than probable that factors other than the presence of IgE (and/or IgG) antibodies, and reactive immune cells in the skin, are responsible for the expression of allergy. Until science is able to elucidate the precise mechanisms responsible for all types of clinical allergy, we must rely on carefully controlled elimination and challenge to accurately identify the foods responsible for the symptoms of allergy.”

http://www.allergyadvisor.com/Educational/March04.htm


Corn Allergy Advocacy/Resources
@CornAllergy911

Wednesday, March 23, 2016

"A 'Roadmap' for Navigating Patient Advocacy," FDA Article

My comment to the FDA's Facebook post:
The best way to navigate patient safety is to inform all medical personnel that they MUST READ product information sheets; e.g., if a patient enters the hospital and declares they are allergic to corn, the medical staff SHOULD KNOW that IV fluid w/corn-derived dextrose CANNOT be administered to the corn-allergic patient.
...
BAXTER LABORATORIES: WARNING ABOUT USING CORN-DERIVED DEXTROSE IV FLUID ON THE CORN-ALLERGIC PATIENT
Excerpt from their product information sheet: "Solutions containing dextrose should be used with caution, if at all, in patients with known allergy to corn or corn products.”  https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/016679s104,016682s105,016692s095,019367s026lbl.pdf

Dangers of Corn NMIs (Non-Medicinal Ingredients) in Medications, Published Article

This published article addresses the dangers of corn/corn derivative NMIs (non-medicinal ingredients) in medications.  I would strongly suggest that you keep this article with you at all times to present to a dismissive physicians/pharmacists falsely claiming that corn is hypoallergenic.

B . C.’ s pharmacy information source, Vol. 32 No. 3, May/June 2007
"Warning: corn-related allergens
Non-medicinal ingredients don’t appear on drug labels"
http://library.bcpharmacists.org/6_Resources/6-7_ReadLinks/ReadLinks-MayJun2007.pdf


Corn Allergy Advocacy/Resources
@CornAllergy911

Monday, March 21, 2016

"Probable Anaphylactic Reaction to Corn-Derived Dextrose IV Fluid Solution," Published Report

The corn allergy community should carry a copy of this article with them at all times, since the majority of medical personnel do not believe that anyone can be allergic to dextrose (they don't understand the difference between dextrose and corn-derived dextrose).


http://www.ncbi.nlm.nih.gov/pubmed/1808842


Corn Allergy Advocacy/Resources
@CornAllergy911

FARE (Food Allergy Research & Education) Conducting Survey of Anaphylactic Reactions

If you or a family member are anaphylactic to corn/corn derivatives, this is a chance to share your personal story with FARE (Food Allergy Research & Education).


[On a personal note, FARE banned me from commenting on their Facebook page after I inquired about the source of their allergy statistics.]



https://www.surveymonkey.com/r/JNR5GKV

FARE's original Facebook post:
https://www.facebook.com/FoodAllergyFARE/posts/10153898841292416?fref=nf


Corn Allergy Advocacy/Resources
@CornAllergy911

Published Study Addressing Psychological Disorders Associated with Food Allergies

"Teenagers with food allergies are more likely to suffer from depression, anxiety or attention-deficit hyperactivity disorder (ADHD), a new study reveals."

Clinicians: Protect Yourself From A Potential Medical Malpractice Lawsuit

  Pursuant to 21CFR184.1857, if a clinician injects any of the named substances listed in this CFR into a patient with a confirmed IgE-media...